Showing results (1-10 of 53) with videos related to
Sort By:
Pageof 6
Drug Discovery Today. Technologies|December 17, 2016
Translational biomarkers: from discovery and development to clinical practiceMeena Subramanyam, Jaya GoyalBioanalysis|November 7, 2015
Immunogenicity evaluation strategy for a second-generation therapeutic, PEG-IFN-β-1aJoleen T White, Mary Crossman, Kelly Richter, et al.Bioanalysis|February 22, 2013
Clinical development of biosimilars: an evolving landscapeMeena SubramanyamJournal of Immunotoxicology|October 30, 2008
Immunogenicity of biotherapeutics-an overviewMeena SubramanyamThe AAPS Journal|August 31, 2013
2012 AAPS National Biotech Conference Open Forum: a perspective on the current state of immunogenicity prediction and risk managementManoj Rajadhyaksha, Meena Subramanyam, Bonnie RupJournal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 16, 2013
Use of a standardized MxA protein measurement-based assay for validation of assays for the assessment of neutralizing antibodies against interferon-βMeenu Wadhwa, Meena Subramanyam, Susan Goelz, et al.Bioanalysis|June 26, 2015
Incurred sample reproducibility and stability assessment in a cell-based drug concentration assayJoleen T White, Mary Crossman, Meena SubramanyamJournal of Immunological Methods|December 7, 2010
Solution ELISA as a platform of choice for development of robust, drug tolerant immunogenicity assays in support of drug developmentAlvydas Mikulskis, Dave Yeung, Meena Subramanyam, et al.Bioanalysis|February 21, 2015
Feasibility of immuno-PCR technology platforms as an ultrasensitive tool for the detection of anti-drug antibodiesDarshana Jani, Edward Savino, Jaya GoyalNucleic Acid Therapeutics|April 11, 2022
Improvements to Hybridization-Ligation ELISA Methods to Overcome Bioanalytical Challenges Posed by Novel Oligonucleotide TherapeuticsJoseph A Haegele, Ramakrishna Boyanapalli, Jaya GoyalPageof 6